Dalton Bioanalytics
Los Angeles · Founded 2019
About Dalton Bioanalytics
Dalton Bioanalytics is a developer of analytical technology that unlocks access to the wealth of information available in the blood. It resolves the inefficiency and expense that plagues traditional laboratory testing by digitizing the biochemical composition of blood and translating that digital signature into a comprehensive array of actionable health insights. The analytical technology deciphers the biochemical signature of blood to build narratives about internal biology. Dalton was headquartered in Los Angeles, California in 2019.
Company Facts
- Founded: 2019
- Legal name: Dalton Bioanalytics Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Jul 2022)
- Website: daltonbioanalytics.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/dalton-bioanalytics-8463795 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.